Form 4: AbbVie CEO Michael Reports Routine Share Disposition

AbbVie's Chairman and CEO, Robert A. Michael, reported the disposition of 36,523 common shares for tax withholding purposes at a price of $232.08 per share.

Summary

• Robert A. Michael, Chairman of the Board and CEO of AbbVie Inc., reported a transaction involving the company's common stock.
• On February 27, 2026, 36,523 shares of common stock were disposed of.
• The transaction code "F" indicates these shares were withheld to cover tax liabilities.
• The price per share for the disposed securities was $232.08.
• Following this transaction, Michael directly beneficially owns 178,737 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary disposition of shares for tax purposes, which is a common occurrence for executives receiving equity compensation and does not signal a change in company fundamentals or management's outlook.

Positives

• The transaction is a routine, non-discretionary event (shares withheld for tax purposes), indicating standard equity compensation practices.

Negatives

• No specific negative aspects are indicated by this routine tax withholding transaction.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those coded 'F' for tax withholding, are common occurrences in the pharmaceutical industry and generally do not reflect a change in management's sentiment towards the company's prospects. Such transactions are standard practice for executives receiving equity-based compensation.

Comparison to Industry Standards

• This type of transaction (shares withheld for tax) is a standard practice across all industries, including pharmaceuticals, for executives receiving equity compensation.
• It aligns with typical corporate governance and compensation structures seen at companies like Pfizer, Merck, and Johnson & Johnson, where executives often have a portion of their vested equity awards withheld to cover income tax obligations.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, non-discretionary transaction for tax purposes, not a discretionary sale indicating a change in sentiment.

Key Dates

Keywords

AbbVie, ABBV, Form 4, Insider Transaction, Robert A. Michael, CEO, Share Disposition, Tax Withholding, Equity Compensation